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and Shekhar Bhansali 1,∗∗,z
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This work reports a biosensor for monitoring xanthine for potential wound healing assessment. Active substrate of the biosensor
has xanthine oxidase (XO) and horseradish peroxidase (HRP) physisorbed on a nanocomposite of multiwalled carbon nanotubes
(MWCNT) decorated with gold nanoparticles (AuNP). The presence of HRP provided a two-fold increase in response to xanthine,
and a three-fold increase in response to the nanocomposite. With a sensitivity of 155.71 nA μM−1 cm−2 the biosensor offers a
detection limit of 1.3 μM, with linear response between 22 μM and 0.4 mM. Clinical sample analyses showed the feasibility of
xanthine detection from biofluids in a lesion site due to diffusion of the analyte into surrounding biofluids. Higher concentrations
by three-fold were observed from wound proximity, than away from injury, with an average recovery of 110%. Results show the
feasibility of monitoring wound severity through longitudinal measurements of xanthine from injured vicinity.
© The Author(s) 2019. Published by ECS. This is an open access article distributed under the terms of the Creative Commons
Attribution 4.0 License (CC BY, http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse of the work in any
medium, provided the original work is properly cited. [DOI: 10.1149/2.0401909jes]
Manuscript submitted February 19, 2019; revised manuscript received May 13, 2019. Published June 10, 2019. This paper is part of
the JES Focus Issue on 4D Materials and Systems.
Inefficient management of wounds leads to delayed healing and,
in some cases, surgeries and amputations.1 Delays in effective treat-
ment can cause acute wounds to turn chronic, leading to hospital stays
and readmissions with prolonged and expensive post-surgical care.
This leads to larger healthcare costs and, in turn, a reduced quality
of life. While technological advances are aiming to improve wound
care, convenient wound therapy remains a significant challenge. Con-
ventional wound-care techniques are limited to patients visiting the
clinic to allow visual inspection of their wounds by clinical staff
within twenty-four hours of occurrence; following up with timely
referrals to therapy as appropriate. Although considerable methods
have been undertaken to improve wound diagnostics, it is still chal-
lenging to precisely quantify how much a wound has healed. Solu-
tions in existing wound-care include Aranz Medical’s2 monitor and
Ekare Inc., which use optical approaches to map the surface are of the
wound and track tissue recovery across the scarred surface.3,4 How-
ever, such practices are possible only at the time of dressing change
and do not offer information on wound dynamics in real-time. There
are gaps yet to be filled in practices for both qualitative and quantitative
wound-care.
A necessary factor for therapy consideration is examination of the
wound bed and its physical measurements through wound boundary
analysis and exudate evaluation. Efforts have been directed to monitor
wound milieu parameters such as pH, temperature, moisture, oxygen
flow and antimicrobial activity.5 Continuous wound monitoring such
as conceptualizing the simultaneous monitoring of pH and temper-
ature of a wound bed, is being explored.6 This is achieved through
investigations of the human purine metabolic pathway. Monitoring
the biochemical activity of the pertaining analytes aids in leverag-
ing biochemical detection of wound severity. Among the different
biomarkers used to determine lesion severity, xanthine is known as an
inflammatory biomarker capable of forming reactive oxygen species
(ROS) such as hydrogen peroxide (H2O2), which promotes healing.
Such species act as scavengers of oxygen radicals to facilitate tissue
recovery. In the case of cell rupture, xanthine is formed in the wound
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(localized xanthine) from the breakdown of released energy of metabo-
lites in the tissue. Increased purine degradation and apoptosis increases
the concentrations of such purine metabolites. Smart bandages utilize
electrochemical approaches to determine wound severity through bio-
chemical monitoring of analytes. Different multi-dimensional mate-
rials and nanotechnology are being extensively explored for the pur-
pose of designing smart, wearable medicinal platforms. Such mate-
rials include carbon, silver, gold and soft, flexible biomaterials (bio-
compatible polymers and hydrogels) to investigate infection control
and promote healing.7–10 These materials claim to assist in providing
an enhanced and stable sensing response to analytes, which can be
correlated with the healing of wounds.
Possible biofluids that can be explored to monitor a wound include
those from in and around an injury. Bio-analytes from wound exudate
tend to attain equilibrium with extracellular fluids such as intersti-
tial fluid, which is transported to neighboring glands. Fluid oozes in
and around the wound through diffusion in the internal dermal and
subcutaneous layers of skin and surrounding blood vessels.11 This oc-
curs due to the differences in osmotic gradients of the metabolites and
components in the biofluids. With elevated xanthine concentrations
at the injury site, its vicinity also has a rise in level. Normal phys-
iological concentrations of xanthine (65–130 μM)12 are elevated to
higher levels in and around a wound. Therefore, biomarkers that have
a correlation with wound healing and its severity can be utilized for
analysis of tissue recovery through their detection from biofluids in
wound proximity.
In this work, an electrochemical sensor for detection of xan-
thine in biofluids of wound exudate and from around the wound
has been presented. Sensor functionalization using two enzymes, XO
and horseradish peroxidase (HRP), notably improved the sensing re-
sponse from facilitated electron transfer between the analyte and the
transducer. Biofluid sample studies from in and around the wound
provided insights into the physiological concentrations of xanthine
in and around an injury. Such detection provides a potential non-
invasive method for the quantification of lesion severity. Through the
utilization of existing cellular biochemical pathways, this work il-
lustrates the viability of an electrochemical approach for detection
of wound severity through direct longitudinal measurements of such
biomarkers.
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Experimental
Materials.—XO lyophilized powder containing 7 U mg−1 was
purchased from Sigma Aldrich and used for xanthine oxidation.
XO enzyme immobilization was performed on screen-printed car-
bon electrodes (SPCE) purchased from CH Instruments, Inc., United
States. 0.2 U ml−1 HRP of analytical grade was used from Ther-
moFisher Scientific. MWCNT (o.d. = 10–20 nm, i.d. = 2–10 nm
and length = 0.5–200 μm), 20 nm Au nanoparticles (0.5 μM), and
dimethylformamide (DMF) were purchased from Sigma Aldrich.
Xanthine, sodium hydroxide (NaOH), hydrogen peroxide (H2O2),
sodium phosphate monobasic (NaH2PO4) and sodium phosphate diba-
sic (Na2HPO4) were used of analytical grade. All aqueous solutions
were prepared using deionized (DI) water. Phosphate buffer solutions
(pH 5 to 8) (20 mM) were prepared using NaH2PO4 and Na2HPO4 salts
and were used as electrolyte solutions. Colorimetric Xanthine assay
kits were purchased from Sigma Aldrich and utilized to analyze clin-
ical samples.
Apparatus and methods.—The working electrode was function-
alized with MWCNT prepared in DMF by drop-casting and drying
at 60°C, followed by AuNP and drying at 60°C. The working elec-
trodes were modified with 20 μg cm−2 MWCNT and 0.5 μM AuNP
(1:1 V/V). Electrode surface characterization was performed using
SEM JEOL 6330. The nano-material functionalized electrodes were
further modified with the enzyme catalysts 0.2 U ml−1 XO and 0.2 U
ml−1 HRP. The ratio of MWCNT:AuNP functionalization was opti-
mized with 1:1, 1:2, 2:1, 1:3 and 3:1 V/V. It was seen that higher
current response was obtained from 1:1 as compared to other ra-
tios (inset: Fig 3b), owing to uniform distribution of MWCNT:AuNP
across the electrode surface. Lower response from increased amounts
of AuNP across the MWCNT decorated surface can be attributed to
reduced electrode surface area, from coverage of the pores on the car-
bon substrate.13 Higher amounts of MWCNT were noted to provide
increased capacitance with a small difference in faradaic current.14
The mixtures of XO and HRP at different molar ratios in PBS (1:1,
1:2, 2:1, 1:3, 3:1) were used to immobilize the enzymes onto the
MWCNT/AuNP modified electrodes. The amounts of XO and HRP
(0.2–0.6 U ml−1) were optimized to obtain improved electron transfer.
It was seen that 1:1 ratio of XO:HRP (0.2 U ml−1) provided higher
signal as compared to the other bi-enzymatic electrodes (inset: Fig 3b).
Reduced current response in higher enzyme ratios can be ascribed to
either lower production of H2O2 from decreased amounts of XO, or
due to reduced electron transfer from lesser amounts of HRP.15 This
shows that 1:1 ratio (0.2 U ml−1 XO:HRP) provided optimum catalytic
response.
All enzyme immobilizations were achieved through drop casting,
nitrogen drying, and rinsing in PBS to remove un-entrapped enzymes
prior to testing. Drying in nitrogen allowed for the removal of ex-
cess water from the electrode surface, forming a gel like structure.16
Physical adsorption of the enzyme on the electrode surface was a
simple and cost-effective method of immobilization, whereby the
enzyme attached to the working electrode surface through van-der-
Waal’s forces.17–19 All steps involving the enzymes were carried
out in an ice-box to reduce enzyme denaturation. Cyclic voltam-
metry (CV) was performed using the analytical system model CHI-
230B potentiostat from CH Instruments, Inc. Standard electrochem-
ical characterizations were carried out in a classical three-electrode
system consisting of SPCE, an external Ag/AgCl as reference elec-
trode, and a Pt counter electrode. This three-electrode system was
tested in an electrochemical cell setup with a 3 mL electrolyte so-
lution to assess the performance of the nanomaterial-enzyme func-
tionalized electrode in different concentrations of xanthine at a pH of
7.8. These measurements were performed at 20 mV s−1 to record
the generated H2O2 at the cathode between −0.1 V and −0.6 V.
The effect of pH on the functionalized sensors was also studied us-
ing different pH solutions (5–10). Control studies were performed
in the absence and presence of different nanomaterials (MWCNT
and Au) with the working electrode being infused with the enzymes
Figure 1. Schematic showing electron transfer mechanism in xanthine oxida-
tion by XO and HRP on a nanocomposite functionalized electrode.
XO and HRP. The electrodes tested were (i) bare, (ii) XO/HRP, (iii)
Au/XO/HRP, (iv) MWCNT/XO/HRP, (v) MWCNT/Au/XO/HRP, (vi)
MWCNT/Au/XO and (vii) MWCNT/Au/HRP. The effect of pH on en-
zyme activity was recorded using an Evolution 201 UV-Visible Spec-
trophotometer, ThermoFisher Sc. The ThermoFisher Sc. microplate
absorbance reader was used to conduct assay experiments.
Xanthine extraction from wound dressing.—Five de-identified
wound dressing samples were collected for xanthine extraction from
patients at the wound clinic in University of Miami. Each dressing,
about 10 cm × 10 cm, was collected from the patient’s injured leg at
the time of their dressing change. The wound dressings were carefully
cut to 5 cm × 5 cm, as shown in Fig 2, to extract the biofluid that
diffused through the dressing. Each of these samples were immersed
in a NaOH solution prepared in DI water (pH 12) and incubated at
37°C for forty-five minutes. They were then ultra-sonicated in a ho-
mogenizer for 60 s at 20 Hz to extract the samples from the dressings.
The extracted solutions of wound exudate and those from perilesional
and healthy skin were tested on the biosensor. Assays for correlating
concentrations of xanthine in the different samples were conducted
using standard colorimetric assay protocol at 570 nm.
Results and Discussion
Enzymatic reaction mechanism and sensor performance.—Xan-
thine dehydrogenase is prevalent in normal tissue and transforms to
XO in the case of injury. XO is an oxidoreductase enzyme with a
cofactor, flavin adenine dinucleotide (FAD), that facilitates its oxida-
tion to a terminal purine product, uric acid (UA). XO has 2 molecules
of FAD bridged by a pair of ferric mercaptide groups.20 Purine sub-
strates bound by the isoalloxazine ring system of one FAD under-
goes oxidation in presence of O2 and H2O (Eq. 1). The presence of
a molybdenum cofactor in XO allows for the transfer of electrons in
the oxidation pathway to convert to by-product H2O2. This oxidation
pathway of xanthine, as illustrated in Fig. 1, was utilized in this study,
with the enzymes acting as natural catalysts to facilitate detection.
The enzymatic oxidation of xanthine was quantified by measuring the
formed H2O2 on the electrode. Electrochemical analyses showed that
XO provided an onset potential of -0.3 V in presence of xanthine with
no defined reduction peak (Fig 3a). This was due to sluggish reduction
in the XO functionalized substrate.
Xanthine + O2 + H2O → Uric acid + H2O2 [1]
Horseradish peroxidase + H2O2 → H2O + O2 [2]
To facilitate the reduction of H2O2 on the electrode, HRP was
introduced in the study. HRP, being a metalloenzyme, has an iron
heme group and contains a histidine residue, which is in a vacant
resting site.21 H2O2 can attach to this vacant site during its reduction-
oxidation reactions, where an oxygen atom can bind during activation.
This position is considered as the active site for enzyme binding.21 The
presence of HRP facilitated the electron transport of H2O2. It can be
observed from Eq. 2 that HRP catalyzes the reduction of H2O2 to
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Figure 2. De-identified wound dressings from 5 patients, subjects 1–5 respectively are shown by green dashed lines (- - -); red dashed lines (- - -) represent the
extraction area of wound exudate; blue dashed lines (- - -) represent the extraction area of biofluid from perilesional skin and pink dashed lines (- - -) represent
healthy skin extracted area.
Figure 3. (a) CV signals of bare, MWCNT/Au functionalized with XO or HRP or both in presence of 32μM xanthine; Insets: (b) Plot depicting change in response
with varied MWCNT/AuNP and XO/HRP functionalization in presence of 32μM xanthine; (c) SEM micrograph of MWCNT/Au electrode surface; (d) CV signals
of bare, XO/HRP electrodes with MWCNT or Au or MWCNT/Au in presence of 32 μM xanthine; Insets: (e) Linear regression plot of the bi-enzymatic sensor, (f)
Linear regression plot of the sensor at elevated concentrations.
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water and oxygen. The presence of HRP was noted to improve elec-
tron transport by facilitating the rapid transfer of electrons between
the enzyme and the transducer. This enabled increased reduction of
H2O2, in turn offering amplified signal output with improved quan-
tification for biomarker detection.22,23 The presence of HRP increased
the current density by 71.42 μA cm−2 at an Epc = 0.5 V in pres-
ence of xanthine. This electrode also displayed lower onset potential
(0.2 V) compared to a single enzymatic electrode. This indicates im-
proved electrocatalytic activity. In comparison, a bare electrode shows
no definite peak due to no formed H2O2. The bi-enzymatic electrode
was thus seen to show an enhanced response to the same concentration
of xanthine. The use of such physiologically relevant enzymes allows
them to act as natural catalysts in detection. Utilizing such enzymes
allows for improved electrocatalytic activity with specific response to
the target analyte.
To enable electron transfer between the electrode and the analyte,
a nanocomposite of MWCNT and Au nanoparticles was investigated
in detection. The presence of isolated MWCNT or Au nanomaterial
on the enzymatic electrode did not provide any defined peak in the
presence of xanthine (Fig. 3d). A MWCNT functionalized enzymatic
electrode provided a 2-fold increase in signal as compared to Au
nanoparticle modified electrode. The presence of a combination of
MWCNT and Au nanocomposite offered a further enhanced response
from the enzymatic electrode at a low onset potential of 0.3 V. An
increase in current signal by 7 μA was observed at an Epc = 0.5 V
with a lower onset potential of 0.2 V.
Electrochemical response from the nanocomposite electrode was
evaluated in the presence of increasing concentrations of xanthine
in the physiologically relevant range. Typical concentrations of xan-
thine are known to vary between 3 and 5 μM in healthy individuals
with therapeutic levels rising from 35 to 160μM.24,25 Sensor response
employing nanomaterials of MWCNT and Au was evaluated within
6μM (inset: Fig 3e) and elevated concentrations (inset: Fig 3f). Sensor
design employing nanomaterials of MWCNT and Au assisted in pro-
viding a linear response between 22 μM and 0.4 mM (inset: Fig 3f),
broader than the physiological range. With a detection limit of 1.3μM,
enhanced performance was recorded (inset: Fig 3e). An increase in Ipc
was recorded when subjected to different increasing concentrations
of xanthine within the physiologically relevant range. This nanocom-
posite modified bi-enzymatic electrode offered a sensitivity of
155.71 nA μM−1 cm−2 through irreversible immobilization of the
enzyme on the working area. An improved response was obtained in
the presence of increased concentrations of xanthine due to increased
reduction of H2O2 on the nanomaterial functionalized bi-enzymatic
sensor. The SEM micrograph (inset: Fig 3c) depicts the surface dis-
tribution of Au nanoparticles decorated over MWCNT on the active
substrate. The combination of these two different kinds of nanostruc-
tures offered a larger surface area for improved enzyme loading (in-
set: Fig 3a). The uniformly spread nanomaterial composite provided
greater electrocatalytic activity ratios.26 This approach incorporating
both enzymes, XO and HRP, in combination with the nanocomposite
of MWCNT and Au nanoparticles allowed for improved quantification
in biomarker detection.27,28
Effect of pH.—Since physiological events are pH-dependent, pH
plays a role in the process of lesion healing. pH within the wound-
milieu influences the biochemical reactions involved and is known to
have a correlation with healing. It affects the cellular events involved
in healing and plays an important role in determining infection con-
trol, antimicrobial activity, and oxygen release in recovery. The pH
of an injured micro-environment is known to be alkaline with a value
between 8 and 10, depending on wound severity and the healing phase.
Chronic non-healing wounds are known to have an elevated alkaline
pH (7.15 to 8.9). As a wound heals, the pH shifts from alkaline (7–9)
to acidic, the normal pH of skin (4–6).16,29–30 Therefore, the enzymatic
response in different pH conditions was explored.
Enzymes are reportedly sensitive to pH and can denature over time
with pH variations. They provide stable performance with retained
activity at specific pH levels.31 XO is known to be active at a slightly
Figure 4. Effect of pH on the current and potential of the bi-enzymatic sensor
in presence of xanthine.
alkaline pH (7.5–7.8), with a pKa value of 6.5 and an isoelectric point
around pH 6.32,33 HRP is known to provide an optimum response
around pH (6–6.5) with a pKa and isoelectric point of 6.4 and 7.2,
respectively.34,35 To understand the activity of XO/HRP in the mixture
and assess the electrochemical activity, the bi-enzymatic sensor was
analyzed over a pH range from 5.5 to 9.5. It was observed that higher
response was obtained between pH 7 and 8 (Fig. 4). An increased
current was obtained at pH 7.5 at a low Epc. There was a shift in the
peak potential with reduced values as the pH changed from acidic to
alkaline. As wounds are known to shift from a higher to a lower pH
with healing, this correlation could potentially enable the calibration
of the enzymatic biosensor as a tool for wound monitoring. These in-
vestigations offer an improved understanding of the pH environments
suitable for enzymatic detection of xanthine. This shows that the bi-
enzymatic sensor can provide responses in physiologically relevant
pH ranges for wound assessment.
Interference studies.—Wound exudate has high protein con-
tent, comprising several electrolytes and inflammatory components.36
Analogy of acute wound fluid has previously shown the presence of
different ions like sodium, potassium, chloride, urea and creatinine;
besides other cytokines, leucocytes, lysozymes, macrophages, neu-
trophils and other microorganisms. Thus, biochemical analysis of a
wound environment using an electrochemical biosensor may be af-
fected by interference from such electroactive species. Among the
wound fluid components, such species are hypoxanthine, uric acid,
ascorbic acid and dopamine. Xanthine is produced from hypoxan-
thine and leads to the formation of uric acid in purine metabolism,
using XO.
XO being the key catalyst in the biosensor, such purine metabolites
are interferents in detection.
Like purine metabolites, the wide presence of electroactive species
like ascorbic acid and dopamine in humans will also interfere with
xanthine detection. Under physiological conditions, interference from
hypoxanthine (8 μM) and uric acid (0.5 mM) were thus investigated,
in the same potential window. It can be seen from Table II, that min-
imal change in response between 3.8% and 9.9% was observed with
the presence of these interferents. With the presence of ascorbic acid
(34 μM), comparatively higher interference was noted, with a change
in response by 11.8%, while dopamine (196 pM) was seen to depict
an interference of 8.8%. Interferent concentrations were chosen as per
the higher biological levels, with detection in presence of lower phys-
iological concentrations of xanthine. This shows that even in presence
of higher concentrations of the common electroactive interferents, the
sensor signal for lowest concentration of xanthine does not deviate
beyond ± 6%. Thus, this enzymatic biosensor can be utilized to de-
termine xanthine in biofluids.
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Figure 5. De-identified wound images of patients diagnosed with venous leg ulcers (a, b) and sickle cell disease leg ulcer (c).
Clinical sample analyses.—Venous leg ulcers and sickle cell dis-
ease leg ulcers of de-identified patients within a week of therapy were
analyzed (Fig. 5). Therapy for such wounds is primarily compression
and pressure oriented, to increase the venous return and reduce ve-
nous hypertension to allay the pressure damage caused in valves of
leg veins.37,38 Analysis from these dressings showed, that the wound
exudate from larger wounds (14 cm2) had 3.25 μM xanthine com-
pared to 2.77 and 1.85 μM for wounds with smaller area of 5 cm2
and 1 cm2, respectively. Such a relationship suggests that a correlation
may be drawn between wound severity and xanthine concentrations;39
wounds with a larger area contain higher concentrations of xanthine
than smaller wounds. A correlation can be drawn between severe
wounds depicting higher concentrations than healing wounds, with
large wounds typically taking longer to heal.40,41 However, larger num-
ber of sample studies are necessary to validate the correlations. This
work focuses on assessing the feasibility of the bi-enzymatic sensor
for xanthine detection in the extracted biofluids from wound exudate,
perilesional and healthy skin. Obtained sensor readings were validated
against standard assay protocols. A correlation between the assay and
sensor measurements was drawn in Table I. It can be seen from Table I
that the biosensor readings have high deviations for wound exudate
measurements as compared to measurements from perilesional and
healthy skin. These deviations are reflected in their recovery values as
seen in the same table, where wound exudate has ∼122% deviation,
while extracts from perilesional and healthy skin have a deviation of
only about 40.48% and 86.41%, respectively. Different wounds con-
tain varying levels of electrolytes and proteins.42 The deviation in
response can also be ascribed to these differences in bio-fluid com-
position. This effect of biofluid occlusion on the active surface of the
biosensor was studied through electrochemical analysis. It showed
the rate of decrease in response to sequential deposition of extracts of
wound exudate and biofluid from around the wound. The bi-enzymatic
sensor showed a gradual decrease in response to extracts from perile-
sional and healthy skin with the same volume of analyte. As illus-
trated in Fig. 6, the rate of decrease in response to wound exudate is
20% more than when subjected to extracts around and away from the
wound. This higher rate of decrease can be attributed to the occlusion
of solid proteins, proteases, cytokines and neutrophils present in the
wound exudate on the active area of the electrode. Such accumulation
tends to block the electrode surface, limiting diffusion of analyte to the
transducer and promoting electrode fouling. Measurements recorded
over the sequential deposition of analyte have shown that the response
of the bi-enzymatic electrode was reduced by only 10% in the pres-
ence of biofluid from healthy skin before attaining stability. It can thus
be said that the bi-enzymatic sensor could potentially be utilized for
wound healing therapy through assessment of xanthine from biofluids
in injured vicinity.
To assess the ability to monitor xanthine from wound vicinity non-
invasively, extracted biofluids from perilesional and healthy skin were
measured, along with exudate extracted from the wound dressings
Figure 6. Percentage change in current response of the biosensor as a function
of volume of extracted biofluids from healthy skin (a), perilesional skin (b) and
wound exudate (c).
Table I. Detection of xanthine in extracted wound exudate, biofluid from perilesional and healthy skin of de-identified patients using the biosensor.
Healthy skin Perilesional skin Wound exudate
Assay Sensor Recovery Assay Sensor Recovery Assay Sensor Recovery
Sample (μM) (μM) (%) RSD (μM) (μM) (%) RSD (μM) (μM) (%) RSD
S1 1.39 1.72 123.94 0.60 1.45 1.91 132.18 0.69 1.46 3.25 222.32 0.37
S2 1.36 1.34 98.47 0.52 1.51 2.12 140.48 0.94 5.63 2.77 49.22 0.10
S3 1.33 1.15 86.22 0.41 1.36 1.54 112.89 0.40 7.48 1.85 24.74 0.11
S4 1.33 2.48 186.41 0.41 2.97 2.74 92.20 0.18 3.35 2.83 84.41 0.25
S5 2.59 2.00 77.29 0.27 2.91 2.23 76.69 0.19 4.50 6.48 143.94 0.12
S1, S2, S3, S4 and S5 represent the samples from de-identified patients.
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Table II. Response of sensor for 3 μM xanthine in absence and presence of interfering biomolecules.
Interfering biomolecules Interferent concentration (μM)
Response without interferent
(μA) Response with interferent (μA) Change in response (%)
Uric Acid 500 12.05 13.25 9.96
Hypoxanthine 8 11.06 11.49 3.89
Ascorbic Acid 34 9.14 10.23 11.93
Dopamine 0.000196 15.51 16.88 8.85
of five different patients. The biosensor was utilized to electrochemi-
cally analyze the extracted bio-fluids and determine the concentrations
of xanthine. Results obtained from this study have been depicted in
Table I and Fig. 7. Analyte concentrations were observed to be higher
from extracted wound exudate than from further away from the injury
site. Biofluids from healthy skin showed comparatively lower concen-
trations. This indicates that concentrations of xanthine are higher in
wound proximity and are reduced when further away from the lesion
site. On the occurrence of a wound, fluid oozes in and around the
punctured tissue by diffusing through glands and surrounding tissue
through the internal, lower dermal layers of skin due to changes in
osmotic gradients of the metabolites.5 Therefore, the area around the
wound also has a rise in analyte concentrations. It can be seen from
this study that measuring xanthine from biofluids in and around the
injury of a person is possible and not at all cumbersome. This shall also
allow to reduce occlusion effects from embedding the sensor directly
on the wound.
Conclusions
A potentiometric biosensor was developed using two enzymes,
XO and HRP, for non-invasive detection of xanthine from wound ex-
udate and biofluids around a wound. Electrochemical analyses from
nanomaterial modified bi-enzymatic electrodes provided enhanced re-
sponses with an increased reduction of by-product H2O2. Linear re-
sponse was obtained with increasing concentrations of xanthine over
the concerned physiological range. The nanomaterial functionalized
bi-enzymatic electrode was used for the detection of xanthine from
wound exudate and biofluid samples from perilesional and healthy
skin. The viability of xanthine detection from wound milieu was ex-
plored through this study. Results have shown the feasibility of de-
Figure 7. Concentrations of xanthine concentrations from extracts of biofluids
sampled from healthy skin (a), perilesional skin (b) and wound exudate (c) of
five de-identified patients using the biosensor.
tection of xanthine from bio-fluid matrices around an injured region,
with portrayed higher concentrations in wound proximity than fur-
ther away. This work paves a potential path for the stable detection of
purine metabolites from biofluids in and around the wound, allowing
for the non-invasive assessment of lesion severity, providing insights
on healing progress.
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